Clinical Trials Directory

Trials / Unknown

UnknownNCT02111265

THe Comparison of Target Controlled Infusion of Propofol or Etomidate at General Anesthesia in Geriatric Patients

The Comparison of Efficacy and Safety of Target Controlled Infusion of Propofol or Etomidate at General Anesthesia in Geriatric Patients --A Randomized Controlled Trial.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University · Academic / Other
Sex
All
Age
60 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Compare the efficacy and safety of closed-loop target controlled infusion of propofol or etomidate at general anesthesia in geriatric patients

Conditions

Interventions

TypeNameDescription
DRUGRemifentanil1. Remifentanil 0.1-0.2μg/ ( kg•min) is continuously pumped at steady speed for analgesia for induction and maintenance of anesthesia. 2. Remifentanil is stopped before skin closure
DRUGCisatracurium1. Cisatracurium 0.15 mg/kg for induction and 0.12 mg/kg/h continuous infusion for maintenance of anesthesia. 2. Cisatracurium is stopped before skin closure.
DRUGSufentanilBefore skin closure, remifentanil is stopped and sufentanyl 0.1μg/kg is given by intravenous injection.
DEVICEBispectral index(BIS) monitorBiS is maintained at 40-60 during anesthesia.

Timeline

Start date
2014-04-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2014-04-11
Last updated
2014-04-14

Source: ClinicalTrials.gov record NCT02111265. Inclusion in this directory is not an endorsement.